WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment

Part of paid clinical trials in Charlotte, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT06291324
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to evaluate the feasibility of using a commercial WATD (Wearable Activity Tracker Device) to collect HRV (Heart Rate Variability) data from pancreatic and breast cancer patients.

Key Dates

Start date
Oct 4, 2024
Status verified
Jan 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
46 participants (estimated)

Primary Outcome Measure

Adherence and acceptability [ Time Frame: Day 14 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Levine Cancer InstituteCharlotteNorth Carolina28204
Maggie Dzhanumova
[email protected]
704-754-3768
Dori Beeler, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charlotte, NC

By condition
Breast cancerPancreatic cancer
By specialty
OncologyBreast oncologyWomen's healthGI oncology
By research site
Levine Cancer Institute· Charlotte, NC

Related Studies